Filter
214
Filtered Results: 214
Text search:
monoclonal
antibodies
Featured
Recommendations
33
New Publications
36
Language
Document type
No document type
83
Guidelines
58
Studies & Reports
30
Manuals
17
Fact sheets
11
Strategic & Response Plan
7
Resource Platforms
3
Training Material
2
Infographics
2
Situation Updates
1
Countries / Regions
Global
15
India
15
South Africa
7
Latin America and the Carribbean
5
Germany
5
Syria
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
Nigeria
2
Niger
2
Afghanistan
2
Africa
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
Russia
2
Mali
2
Indonesia
2
Pakistan
2
North Macedonia
1
Colombia
1
Mexico
1
Ukraine
1
El Salvador
1
Turkey
1
Benin
1
Sierra Leone
1
Rwanda
1
Kazakhstan
1
Chile
1
Cameroon
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
USA
1
Haiti
1
Dominican Republic
1
Tanzania
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Uganda
1
Nicaragua
1
Brazil
1
Namibia
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Ecuador
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
46
Clinical Guidelines
34
Public Health
15
Pharmacy & Technologies
11
Women & Child Health
6
Capacity Building
2
Key Resources
2
Toolboxes
COVID-19
65
Rapid Response
15
Ebola & Marburg
13
NTDs
12
HIV
11
NCDs
9
Pharmacy
7
Polio
7
AMR
6
Health Financing Toolbox
5
Mental Health
4
Planetary Health
3
Cholera
2
Zika
2
Refugee
1
Natural Hazards
1
TB
1
Caregiver
1
Malaria
1
Conflict
1
Accessed Febr. 6, 2020
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
10 December 2020
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr...
3rd Edition – July 2017
www.msfaccess.org
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
